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cAMP response element modulator (CREM)-mediated gene expression is an essential regulatory
mechanism for germ cell differentiation. CREM and its coactivator in testis, ACT, activate the tran-
scription of many essential genes for spermatogenesis. Sperm associated antigen 8 (SPAG8) is a tes-
tis-speciﬁc component that is expressed during germ cell differentiation. In this study, we found the
pattern of SPAG8 expression largely overlapped with that of ACT during spermatogenesis and veri-
ﬁed the association of SPAG8 with ACT. Furthermore, we showed that SPAG8 enhanced the tran-
scriptional activation of ACT-mediated CREMs by strengthening the binding of ACT to CREMs.
These results indicate that SPAG8 acts as a regulator of ACT and plays an important role in CREM-
ACT-mediated gene transcription during spermatogenesis.
Structured summary:
MINT-7892874: CREM tau (uniprotkb:P27699-1) physically interacts (MI:0915) with ACT (uni-
protkb:Q9WTX7) by anti tag coimmunoprecipitation (MI:0007)
MINT-7892809: ACT (uniprotkb:Q9WTX7) physically interacts (MI:0915) with SPAG8 (uniprotkb:B9EKF1)
by pull down (MI:0096)
MINT-7892820, MINT-7892840, MINT-7892987, MINT-7892854: ACT (uniprotkb:Q9WTX7) physically
interacts (MI:0915) with SPAG8 (uniprotkb:B9EKF1) by anti tag coimmunoprecipitation (MI:0007)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
As a master transcriptional activator during spermatogenesis,
cAMP response element modulator (CREM) mediates the tran-
scription of many post-meiotic genes (e.g., Tnp1, Tnp2, Prm1 and
Prm2) via binding the cAMP response element (CRE) in the
promoters [1,2]. These gene products are responsible for chroma-
tin remodeling and spermatid elongation. Due to alternative pro-
moters, splicing events and translation initiation, the Crem gene
generates a series of CREM proteins that function as either tran-
scriptional activators (e.g. CREMs) or transcriptional repressors
[3–6]. CREMs is the most abundant activating isoform in mouse
testis at puberty and is highly expressed in spermatids [7–9]. Sper-chemical Societies. Published by E
g@imicams.ac.cn (L. Wang).matogenesis in Crem-null male mice is blocked at the round sper-
matid stage and thereby causes sterility [7,10]. In contrast with its
activation via phosphorylation and association with CBP in so-
matic cells, the transcriptional activity of CREM is mainly activated
by its coactivator, activator of CREM in the testis (ACT) [11,12].
ACT is composed of four and a half LIM domains, each containing
two zinc ﬁnger motifs. The CREM–ACT complex mediates the
expression of many post-meiotic genes that are essential for nor-
mal spermatogenesis, thus providing a tissue-speciﬁc modulation
mechanism for CREM transcription activity [13–16]. Although
the regulatory pathway of the CREM–ACT complex is essential
for spermatogenesis, the mechanism of how ACT mediates the
transcription activity of CREMs is currently unknown. Therefore,
the investigation of other regulators or general transcription
factors that could be associated with ACT during spermatogenesis
would contribute to the understanding of this regulatory
pathway.lsevier B.V. All rights reserved.
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hSMP-1 or HSD-1, was isolated from a human testis expression
library using anti-sperm antibodies obtained from the serum of
an infertile woman. SPAG8 is localized in spermatids and in the
head and tail of sperm in rat testis [17,18], suggesting a role for
SPAG8 in germ cell differentiation. In our previous study, we found
that ACT interacts with SPAG8 by yeast two-hybrid using SPAG8 asFig. 1. The expression of SPAG8 is tissue-speciﬁc and cell stage-speciﬁc. (A) Monitoring o
analyzed with an immunoblot assay with the anti-SPAG8 antibody. GAPDH served as a lo
the testes of mice at different ages (as indicated) were analyzed with an immunoblot ass
RT-PCR using Spag8 speciﬁc primers. b-Actin served as an internal control. (D) Expressio
week-old mice and used for immunoﬂuorescence staining using the anti-SPAG8 antibody
spermatocyte; RS, round spermatid; ES, elongating spermatid; MS, mature spermatozoobait, which suggests that SPAG8 could be associated with ACT dur-
ing spermatogenesis.
In this study, we generated a SPAG8 antibody and found that
SPAG8 distribution largely overlapped with that of ACT during tes-
tis development. Furthermore, we found that SPAG8 enhanced the
transcriptional activation of ACT-mediated CREMs and the binding
of ACT to CREMs. These results indicate that SPAG8 may be in-f SPAG8 expression in various mouse tissues. Tissue extracts from Balb/c mice were
ading control. (B) SPAG8 expression during testis development. Tissue extracts from
ay. (C) Total RNA extracted from puriﬁed germ cells (as indicated) was analyzed by
n of SPAG8 in germ cells. Squash preparations were prepared from the testes of 8-
and DAPI. Red indicates SPAG8 immunoreactivity. Sg, spermatogonia; P, pachytene
n. Magniﬁcation, 400.
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ACT complex during spermatogenesis.
2. Materials and methods
2.1. Plasmid construction
To generate expression plasmids for HA- and Myc-SPAG8,
Spag8 coding sequence (corresponding to amino acids 1–412)
was ampliﬁed using forward 50-ATGGAGACCACCGAGTCTACA-
GAGG and reverse 50-GTCGCCCACACACACCGGTAGC primers from
mouse testis cDNA and subcloned into the pcDNA6/V5-HisB and
pcDNA6/myc-HisB vectors (Clontech). Various deletion
fragments of SPAG8 with the Myc epitope were generated in
a similar manner, resulting in Myc-SPAG8-N1(1–256), Myc-
SPAG8-N2(1–140), Myc-SPAG8-N3(1–103), Myc-SPAG8-M(104–
256), Myc-SPAG8-C1(256–412) and Myc-SPAG8-C2(312–412).
Full-length Act was ampliﬁed using forward 50-ATGACAAGTAGT-
CAATTTG and reverse 50-GTCTCTTTCTAAGCGTCAGTGTC primers
from testis cDNA and subcloned into the p3xFlag-CMV-14 vector
to generate an expression plasmid for Flag-ACT. Various deletion
fragments of ACT with the Flag epitope were generated in a sim-
ilar manner, resulting in Flag-ACTD1/2, Flag-ACTD1/2-1, Flag-
ACTD4, Flag-ACTD3-4 and Flag-ACTD2-4 (the numbers denote
the position of the LIM domains of ACT from the N-terminus to
the C-terminus). For bacterial expression, full-length Act was sub-
cloned into pGEX-6p-1 (Promega), generating a plasmid for the
expression of a glutathione S-transferase (GST) fusion protein
(GST-ACT). pCMV-6Myc-CREMs (wt and S117A) and pGL3-5CRE
(CRE sequence derived from the somatostatin gene promoter)
were kind gifts from Prof. Hiroshi Nojima (Osaka University, Ja-
pan) [13]. The CREMs activation domain and its mutant, which
contains a mutation of serine 117 to alanine, were cloned intoFig. 2. Association of SPAG8 with ACT in vitro and in vivo. (A) Pull-down assay perform
served as the negative control. # and * indicate full-length and partially degraded GST-AC
SPAG8 protein. (B) HEK293T cells were co-transfected with Flag-ACT- and Myc-SPAG8-ex
tag antibodies as indicated. Lanes labeled ‘‘Input” were loaded with 5% of the total cellthe pGBDT7 vector with the coding sequence of the Gal4 DNA-
binding domain to generate Gal4DBD-CREMs and Gal4DBD-
CREMsS117A, respectively. All construct sequences were veriﬁed
by sequencing analysis.
2.2. Generation of SPAG8 antibody and Western blot
SPAG8 antibody was generated in rats immunized with a re-
combinant polypeptide of mouse SPAG8. The DNA fragment for
residues Asn1–Asn768 of SPAG8 was subcloned into the pGEX-
6P-1 plasmid. The soluble, 72-kDa GST-SPAG8(1–253) fusion pro-
tein was puriﬁed using glutathione-sepharose 4B beads. After
GST was separated from GST-SPAG8 protein, the puriﬁed SPAG8
polypeptide (1 mg/ml) was used as a SPAG8 antigen, and Rat
anti-SPAG8 antiserum was generated by sequential immunization
with 100 lg of puriﬁed protein.
Tissues, including testes from 1-, 2-, 3- and 4-week-old and
adult Balb/c mice were collected and homogenized in lysis buffer
containing 50 mM Tris–HCl (pH 7.4), 0.1% SDS, 1% Triton X-100,
150 mM NaCl, 1 mM phenylmethylsulfonyl ﬂuoride and 10 lg/ml
leupeptin. Aliquots containing 100 lg of total protein were ana-
lyzed by Western blot using anti-SPAG8 and b-actin antibodies.
2.3. Isolation of germ cells, RNA isolation and RT-PCR
Germ cells were isolated from the testes of adult Balb/c mice as
described [19]. Brieﬂy, the tunica albuginea of the mouse testis was
removed. The remaining tissues were digested with 0.5 mg/ml col-
lagenase (Gibco) in DMEM with 0.5% BSA at 32 C for 15 min. After
the addition of PBS containing 1 mM EDTA, the tubule suspension
was transferred into a conical tube and left standing for 5 min to
precipitate tubule fragments. The supernatant, which contained
Leydig cells, was discarded. The tubules were reincubated ined with testes extracts of 12-week-old mouse and GST-ACT and GST. GST protein
T proteins, respectively. § indicates a non-speciﬁc band, and an arrow points to the
pressing vectors. Cell lysates were coimmunoprecipitated with the appropriate anti
lysates.
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ing 1 mM EDTA to remove residual Leydig cells and washed with
PBS containing 1 mM EDTA. The cell suspensions were fractionated
by unit gravity sedimentation on a BSA gradient. The purity of the
enriched populations of spermatogonia, pachytene spermatocytes,
round spermatids, and elongated spermatids was between 85% and
90%. Total RNA from isolated germ cells was extracted using the
TrizolRNA Isolation Kit (Invitrogen). cDNA products were ob-
tained using the Reverse transcription system (Promega) and
ampliﬁed by PCR with speciﬁc Spag8 and b-actin primers.
2.4. Immunoﬂuorescence
Seminiferous tubules were isolated from adult Balb/c mice.
After incubation in 0.5 mg/ml collagenase in DMEM with 0.5%
BSA for 15 min, seminiferous tubules were digested into single
cells or clumps of cells. The cells were squashed onto glass slides.
The cells were then ﬁxed with 4% paraformaldehyde and perme-
abilized with 0.5% Triton X-100. Non-speciﬁc sites were blocked
with 5% bovine serum albumin for 1 h. The immunoﬂuorescence
analysis was performed using the anti-SPAG8 antibody. AlexaFluor
goat anti-rat IgG was used as the secondary antibody (Invitrogen).Fig. 3. Characterization of the interacting regions of SPAG8 and ACT. (A) Schematic align
Lysates of HEK293T cells expressing Myc-tagged SPAG8 or its deletion mutants togethe
Precipitates were immunoblotted (IB) for associated proteins using the appropriate anti
Boxes depict the LIM domains. (D) Expression plasmids of Myc-tagged SPAG8 and Fl
immunoprecipitated (IP) with an anti-Flag antibody. Immunoprecipitated fractions we
antibody.2.5. Pull-down assay
Recombinant GST-ACT protein was puriﬁed from the Escherichia
coli BL21 strain with glutathione-sepharose (Amersham Pharma-
cia). Twelve-week-old mouse testes were collected in lysis buffer
containing 50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1% Triton X-
100, 1 mM NaF, 10% glycerol, 1 mM phenylmethylsulfonyl ﬂuoride
and a protease inhibitor cocktail (Roche). Following sonication and
centrifugation, aliquots of total protein were mixed with puriﬁed
GST-ACT and GST protein, respectively. The mixture was rotated
at 4 C overnight, and 30 ll glutathione-sepharose 4B was added.
The resultant protein was subjected to Western blot analysis after
extensive washing using an anti-GST antibody (Sigma) and the
anti-SPAG8 antibody.
2.6. Cell culture, transfection and dual luciferase reporter assays
HEK293T cells (in DMEM, 10% FBS) were transfected with the
ﬁreﬂy luciferase expression plasmid and the renilla luciferase
expression vector pRL-TK and the indicated expression constructs
(see Figs. 4 and 6) using the Engreen transfection reagent. Thirty-
six hours after transfection, the cells were lysed in a passive lysisment of full-length SPAG8 with the deletion fragments used in the experiments. (B)
r with Flag-tagged ACT were immunoprecipitated (IP) using an anti-Flag antibody.
bodies. (C) Schematic illustration of the ACT deletion fragments used in this study.
ag-tagged ACT or its deletion mutants were co-transfected in HEK293T cells and
re analyzed by immunoblotting (IB) using an anti-Myc antibody or an anti-Flag
H. Wu et al. / FEBS Letters 584 (2010) 2807–2815 2811buffer and assayed for ﬁreﬂy and renilla luciferase activities using
the Dual Luciferase Assay System (Promega). The results were nor-
malized against renilla luciferase activity. The data shown are from
at least three independent transfection experiments with a varia-
tion of less than 12% between the measurements.
2.7. Co-immunoprecipitation assays
HEK293T cells were transfected with the appropriate expres-
sion vectors and collected in 1 ml EBC (50 mM Tris–HCl [pH 7.5],
170 mM NaCl, 0.5% NP-40, 50 mM NaF) containing 1 mM PMSF
and a protease inhibitor cocktail (Roche). The lysates were centri-
fuged at 17 400g for 15 min at 4 C. The supernatants were then
precleared for 30 min with 50 ll Protein A-Sepharose (Roche). The
supernatants were subsequently incubated with the appropriate
antibodies with rotation overnight at 4 C. Protein A-Sepharose
was then added to precipitate this mixture. After extensive wash-
ing, the precipitated proteins were subjected to Western blot anal-
ysis using the appropriate antibodies.Fig. 4. SPAG8 enhances ACT-mediated CREMs transcriptional activation. (A) Expressi
expressing vector were co-transfected with the reporters in HEK293T cells. Cell lysates w
were co-transfected with expression vectors for ACT and CREMs and a CRE-Luc reporter,
vector. (C) HEK293T cells were co-transfected with expression vectors for the SPAG8 del
lysates were subjected to luciferase assays. All data are shown as the mean ± standard d
Renilla luciferase activities obtained from pRL-TK, which served as a transfection contro3. Results
3.1. Expression of SPAG8 is testis-speciﬁc and cell stage-speciﬁc during
spermatogenesis
To assess the tissue-speciﬁc function of the SPAG8 protein, it is
essential to determine its tissue distribution. An anti-SPAG8 poly-
clonal antibody was generated to analyze the tissue distribution of
the SPAG8 protein. The SPAG8 protein was mainly expressed in the
testis compared with other tissues examined (Fig. 1A, lane 1). To
determine the pattern of SPAG8 expression in the developing
mouse testis, extracts from 1- to 4-week-old and adult Balb/c
mouse testes were analyzed by Western blot. The results showed
that the expression of the SPAG8 protein was very low at 3 weeks
(Fig. 1B, lane 3); subsequently, levels were markedly elevated by
the fourth week and into adulthood (Fig. 1B, lanes 4 and 5).
We further examined Spag8 expression in puriﬁed germ cells by
RT-PCR. The Spag8 transcript was produced in spermatocytes and
spermatids, but was absent in spermatogonia (Fig. 1C). Immunoﬂu-on vectors for Gal4DBD-CREMs and ACT and increasing amounts of the SPAG8-
ere subjected to dual luciferase assays. (B) Luciferase assays of HEK293T cells that
which contains somatostatin CRE, with increasing amounts of the SPAG8-expressing
etion mutant-expressing vectors and different expression constructs as shown. Cell
eviation from three independent experiments. The results were normalized to the
l.
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ized to the nucleus and cytoplasm of spermatocytes and round
spermatids (Fig. 1D, upper two panels). In elongated spermatids,
immunostaining signals of SPAG8 were cytoplasmic, whereas no
signal was observed in the nucleus (Fig. 1D, second panel from
the bottom). In addition, SPAG8 expression appeared to be concen-
trated in the region of the acrosome and the middle piece of the tail
in mature spermatozoa (Fig. 1D, bottom panel). In contrast, SPAG8
immunoreactivity was absent in spermatogonia (Fig. 1D, upper pa-
nel). Taken together, this spatial and temporal expression pattern
of SPAG8 suggests that SPAG8 functions in a germ cell type- and
stage-speciﬁc manner during spermatogenesis.
3.2. Interaction of SPAG8 and ACT in vitro and in vivo
ACT is initially expressed in pachytene spermatocytes. During
spermatid elongation, it localizes to the nucleus of round sper-
matids but exits the nucleus to the cytoplasm as cells differenti-
ate to elongated spermatids [20,21]. This pattern of ACT
expression coincides with that of SPAG8, indicating that the
two proteins display a coupled intercellular localization in male
germ cells. Based on the result of a yeast two-hybrid assay in
which SPAG8 was used as bait and on the distribution patterns
of ACT and SPAG8 during testis development, we performed an
in vitro pull-down assay using puriﬁed GST-ACT to precipitate
testis proteins. Although the GST-ACT fusion protein was slightly
degraded (indicated by *), full-length GST-ACT was clearly de-
tected (indicated by #) and deemed sufﬁcient to perform the
pull-down assays (Fig. 2A, lanes 3 and 4). The SPAG8 protein
was associated with GST-ACT in vitro (lane 8), but not with
GST alone (lane 7). We further determined the association be-
tween SPAG8 and ACT in HEK293T cells by co-immunoprecipita-
tion assays. The results showed that SPAG8 was associated with
ACT in the immunoprecipitated complexes from co-transfected
cells (Fig. 2B, lanes 6 and 12). We could not perform endogenous
immunoprecipitation experiments because the anti-ACT antibody
showed non-speciﬁc detection of proteins in a testis extraction
(data not shown).Fig. 5. SPAG8 enhances the binding of ACT to CREMs in HEK293T cells. (A) HEK293T
immunoprecipitated (IP) with an anti-Myc antibody. Immunoprecipitated fractions w
antibody, respectively. (B) Myc-CREMs and Flag-ACT expression vectors and increasing
immunoprecipitated (IP) with an anti-Myc antibody. The 55-kDa band in the second an3.3. Amino acids 140–412 of the SPAG8 sequence and the three C-
terminal LIM domains of ACT are involved in the interaction between
SPAG8 and ACT
To characterize the regions of SPAG8 and ACT responsible for the
interaction, we performed deletion assays and cell immunoprecip-
itation assays. We constructed deletion mutants of SPAG8, as
shown in the schematic drawing (Fig. 3A). The interaction between
ACT and the SPAG8 deletion mutants was investigated by coimmu-
noprecipitation assays. Immunoprecipitation of the Flag-tagged
ACT coprecipitated SPAG8-N1(1–256), SPAG8-M(103–256),
SPAG8-C1(257–412) and SPAG8-C2(312–412) (Fig. 3B, lanes 6–8).
In contrast, no coprecipitation of SPAG8-N2(1–140) or SPAG8-
N3(1–103) was observed (Fig. 3B, lanes 4 and 5). This deletion
analysis demonstrated that two domains in SPAG8, the ﬁrst within
140–256 and the second within 257–412, are involved in its inter-
actionwith ACT. Either domain could interact with ACTwithout the
other. To assess which LIM domains of ACT are responsible for its
interaction with SPAG8, we further generated some deletion mu-
tants of ACT (Fig. 3C) and performed a co-immunoprecipitation as-
say. The ACT fragments that lacked the N-terminal half LIM domain
and the ﬁrst full LIM domain (Flag-ACTD1/2-1) or the C-terminal
third and fourth LIM domains (Flag-ACTD3/4) bound to SPAG8
(Fig. 3D, lanes 4 and 6), while the ACT fragments that lacked the
three C-terminal LIM domains (Flag-ACTD2-4) were completely un-
able to interactwith SPAG8 (lane 7). Therefore, it is possible that the
second LIM domain is essential for the binding of ACT to SPAG8.
3.4. SPAG8 enhances the transcriptional activation of ACT-mediated
CREMs
Because ACT is believed to function as a trans-activator of CREM
during spermatogenesis [12,13], we wanted to determine whether
SPAG8 can affect ACT-mediated CREMs transcriptional activation.
Thus, we performed dual luciferase reporter gene assays by
cotransfecting HEK293T cells with a reporter plasmid containing
a Gal4DBD-CREMsAD binding site upstream of the ﬁreﬂy luciferase
cDNAwith or without theMyc-SPAG8-expressing vector. We foundcells were co-transfected with Myc-CREMs and HA-SPAG8 expression vectors and
ere analyzed by immunoblotting (IB) using an anti-HA antibody and an anti-HA
amounts of the SPAG8-expressing vector were transfected in HEK293T cells and
d third panel from the top corresponds to the heavy chain of immunoglobulin.
Fig. 6. Phosphorylation of CREMs Ser117 is not a requirement for SPAG8 activity in cultured cells. (A) SPAG8 enhances ACT-mediated CREMs transcriptional activation
independent of Ser117 in HEK293T cells. Left, Sequence of the peptide within the CREMs activation domain, which contains Ser117, compared with its mutated counterpart
(CREMsAla117). Right, Luciferase assay of HEK293T cells transfected with expression vectors for Gal4DBD-CREMs or Gal4DBD-CREMsS117A with or without different
expression plasmids as shown. (B) HEK293T cells were transfected with expression vectors for Myc-CREMs or Myc-CREMsS117A and Flag-ACT together with HA-SPAG8.
Immunoprecipitation (IP) was performed with an anti-Myc antibody and precipitates were immunoblotted (IB) for associated proteins using anti-HA, anti-Flag and anti-Myc
antibodies.
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in a dose-dependent manner (Fig. 4A). Similar results were ob-
tained with full-length CREMs on a CRE-driven somatostatin repor-
ter promoter (Fig. 4B). These results indicated that SPAG8 possibly
enhanced ACT-regulated CREM transcriptional activation. To fur-
ther determinewhich region of SPAG8was responsible for the tran-
scription activation property, luciferase assays with deletion
mutants of the SPAG8 expression plasmids were performed. The re-
sults of this analysis showed that various regions of SPAG8 contrib-
uted differentially to the transcriptional activation function of
SPAG8. Amino acids 103–256 of the SPAG8 sequence appeared to
play the primary role in activation (Fig. 4C, lane 6). In contrast,
the C-terminal region (residues 257–412 of SPAG8) seemed to play
a minor role (lane 7). However, none of these deletions demon-
strated the complete activity of the intact protein, indicating that
the structural integrity of SPAG8 is necessary to enhance the tran-
scriptional activation of ACT.
3.5. SPAG8 markedly enhances the binding of ACT to CREMs
ACT interacts with CREMs in spermatids [12]. Thus, we investi-
gated whether SPAG8 associates with CREMs. To test this theory,
we co-transfected HEK293T cells with HA-SPAG8 and Myc-CREMs
expression vectors and performed a co-immunoprecipitation assay.
The result of this assay revealed that SPAG8 did not directly interactwith CREMs (Fig. 5A). However, whenHEK293T cellswere co-trans-
fected with Myc-CREMs- and Flag-ACT-expressing vectors together
with increasing amounts of the HA-SPAG8-expressing vector, the
amount of Flag-ACT coprecipitated by Myc-CREMs increased with
increasing HA-SPAG8 expression (Fig. 5B, lanes 3–6, upper panel).
In contrast, no precipitation of HA-SPAG8was observed in the pres-
ence or absence of Flag-ACT (Fig. 5B, lanes 2 and 4–6, second panel
from the upper). These results indicate that although SPAG8 cannot
form a complex with ACT and CREMs, SPAG8 has the potential abil-
ity to enhance the binding of ACT to CREMs.
3.6. The transcriptional activity of ACT and the binding of ACT to
CREMs, which is enhanced by SPAG8, are independent of CREMs
Ser117 phosphorylation
Phosphorylation of Ser117 within the CREMs is essential for its
association with CBP in somatic cells, whereas ACT activates the
transcriptional activity of CREMs in a phosphorylation- and CBP-
independent manner in germ cells [12,22]. We investigated
whether this function of SPAG8 is dependent on the phosphoryla-
tion of CREMs Ser117. To test this, we converted Ser117 to alanine
to construct the Gal4DBD-CREMsS117A and Myc-CREMsS117A
expression vector (Fig. 6A, left panel) and performed a luciferase
assay and co-immunoprecipitation experiment. The results of the
luciferase assay showed that SPAG8 enhanced the transcriptional
2814 H. Wu et al. / FEBS Letters 584 (2010) 2807–2815activation of ACT-medicated CREMs Ser117A (Fig. 6A, right panel,
lane 4). The results of co-immunoprecipitation experiment showed
that the binding of ACT to Myc-CREMsS117A was also markedly
enhanced by SPAG8 (Fig. 6B, lane 8, upper panel). These results
indicate that the transcriptional activation of SPAG8 on ACT-med-
iated CREMs is not dependent on the phosphorylation of CREMs
Ser117 in cultured cells.4. Discussion
CREM-mediated gene expression is an essential regulatory path-
way for the spermiogenic program. CREM and its coactivator, ACT,
work together to activate the expression of many essential post-
meiotic genes [2,3,9]. However, very few studies have been per-
formed to elucidate the other factors involved in the complicated
transcriptional regulation that occurs during spermatogenesis. In
the present study, we found that the SPAG8 protein is speciﬁcally
and highly expressed in the testis, which coincides with its mRNA
expression, as demonstrated by our previous work [18]. SPAG8
expression in mouse testis occurs initially from the third post-natal
week, at which time late pachytene spermatocytes and round sper-
matids accumulate. This result is in accordance with those of our
cell immunoﬂuorescence assay, in which SPAG8 was expressed
from the spermatocyte to the mature sperm stage. The distribution
of SPAG8 in spermatids largely overlaps with that of ACT [15,20,23],
indicating that SPAG8may associatewith ACT during spermatogen-
esis. However, SPAG8 expression in germ cells is not restricted to
cell stages that express ACT. We found that SPAG8 is also expressed
in the head andmiddle piece of the tail of themature spermatozoon
where ACT is absent, indicating that SPAG8 has other roles in ma-
ture spermatozoa, as described previously [24,25]. For example,
Cheng et al. showed that a SPAG8 antibody inhibits themouse acro-
some reaction and sperm-zona pellucida binding [25].
ACT can powerfully activate the transcriptional activity of
CREMs by interacting with it [2,5]. We also found that SPAG8 en-
hances the transcriptional activation of ACT-regulated CREMs in
cultured cells. This enhanced transcriptional activation may be
mainly due to the ability of SPAG8 to remarkably enhance the
binding of ACT to CREMs. SPAG8 interacts with ACT, but not with
CREMs, whether CREMs is in complex with ACT or not, indicating
that SPAG8 does not directly bind to the CREMs–ACT complex.
However, the underlying mechanism of how SPAG8 regulates the
binding of ACT to CREMs remains unknown. We speculate that it
is possibly related to nuclear transport in a microtubule-dependent
manner. First, the pattern of SPAG8 expression in germ cells indi-
cates a possible shuttling activity for this protein, which can be
supported by our previous study that SPAG8 has a close relation-
ship with microtubules and its location in CHO cells that stably ex-
press SPAG8 changes with the progress of the cell cycle [26].
Furthermore, SPAG8 has been conﬁrmed to associate with RanBPM
[27]. RanBPM is a Ran-binding protein in the microtubule-organi-
zation center, which has a role in Ran-dependent nuclear transport
[28]. SPAG8 may have a similar role to transport ACT into the nu-
cleus of round spermatids, although further experiments are re-
quired to validate this hypothesis.
In conclusion, the present study demonstrated that SPAG8 is a
novel regulator that enhances the transcriptional activation of
ACT-mediated CREMs. This ﬁnding allows us to more deeply
understand the complicated transcriptional regulation that occurs
during spermatogenesis.
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